SARS-CoV-2-IN-23

• UNSPSC Description:

  SARS-CoV-2-IN-23 (compound GRL-0617) is a SARS-COV-2 papain-like protease (PLpro) inhibitor with an IC50 value of 2.3 μM[1].

• Target Antigen:

  SARS-CoV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/sars-cov-2-in-23.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC1=CC=C(C=C1C(C([C@@H](C2=CC=CC3=CC=CC=C32)C)N)=O)N

• Molecular Weight:

  318.41

• References & Citations:

  [1]Ferreira GM, et al. Inhibitor induced conformational changes in SARS-COV-2 papain-like protease. Sci Rep. 2022 Jul 8;12(1):11585.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported